“…The clustered regularly interspaced short palindromic repeat (CRISPR) technology has paved an innovative way for nucleic acid detection. 13 Owing to their intrinsic specificity and sensitivity, platforms based on Cas9, Cas12a, [14][15][16] Cas13, 17,18 and Cas14 19 have all been established and implemented for biomedical analysis. Recently, CRISPR/Cas-based multiplex biosensing has been attracting more and more research interests.…”